Home >> News >> Radiodermatitis Market (4.18% CAGR) 2017-2025: Global Business Growth, Size and Forecast

Radiodermatitis Market (4.18% CAGR) 2017-2025: Global Business Growth, Size and Forecast

The latest market report published by Acute Market Reports, Inc., the global radiodermatitis market was valued at US$ 295.5 million in 2016 and is expected to reach US$ 430.9 million by 2025 with a CAGR increase of 4.18 per cent from 2017 to 2025.

Market Insights

According to a report published in the European Oncology Nursing Society in 2016, as many as 95 per cent of oncology patients who opt for radiation therapy will experience some degree of reaction on their skin due to radiation therapy. Currently, there is no evidence to support any medication that is present to prevent radiodermatitis. Some general guidelines have been considered for the effective management of radiodermatitis in oncology patients previously undergone radiation therapy such as gentle washing and drying, topical moisturizers should be applied before radiation therapy. Additionally usual hygiene practices must be followed such as use of mild detergent, deodorants not to be used on the exposed area, and smoking should be avoided.

Browse Full Report Originally Published by Acute Market Reports at https://www.acutemarketreports.com/report/radiodermatitis-market

In 2016, the top-level segment held the largest market share due to key drivers, such as corticosteroids, is considered to be the gold standard for the treatment of radiodermatitis and increasing demand for hydrophilic creams that have been effective in overcoming patients ‘ discomfort by providing moisture to the dry skin desquamation area. Dressings will be the fastest growing segment in the 2017-2025 forecast period. Mainly due to factors such as increasing oncology patients opting for radiation therapy, there is a wide range of dressings available for the degree of skin complications due to radiation therapy. Technology advancements with hydrocolloid and hydrogel coatings are finding tremendous applications as they are used for the management of moist desquamation in order to promote a moist environment to facilitate reepithelisation.

In 2016, North America held the largest revenue share, mainly due to factors such as increasing radiodermatitis prevalence, an affordable reimbursement scenario, and the existence of advanced research and healthcare institutions. Asia Pacific will be the fastest-growing market in the 2017-2025 forecast period, mainly due to factors such as increasing radiodermatitis prevalence, a competitive market due to the presence of existing and emerging manufacturers involved in palliative radiodermatitis treatment, increasing disposable income in these regions and a thriving online market for the sale of rad medicines.

Key Market Movements:

  • Rising demand for radiation therapy among the oncology patients
  • Merger and acquisition between healthcare industries has resulted in the expansion of product portfolio for radiodermatitis treatment
  • Supportive regulatory environment for radiodermatitis drugs
  • Affordable reimbursement scenario for the treatment of radiodermatitis in developed countries

You can get the sample copy of this research by Acute Market Reports here: https://www.acutemarketreports.com/sample-request/58693

Table of Content

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Radiodermatitis Market Portraiture
2.1.1. Global Radiodermatitis Market, by Product, 2016
2.1.2. Global Radiodermatitis Market, by Geography, 2016

Chapter 3. Global Radiodermatitis Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Radiodermatitis Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Radiodermatitis Market, by Product
4.3. Topical
4.3.1. Antibiotics
4.3.2. Hydrophilic Creams
4.3.3. Corticosteroids
4.3.4. Others
4.4. Dressing
4.4.1. No String Barrier Films
4.4.2. Honey Impregnated Gauze
4.4.3. Hydrogel and Hydrocolloid Dressings
4.4.4. Silicone Coated Dressings
4.4.5. Others
4.5. Oral

Chapter 5. Global Radiodermatitis Market, by Geography, 2015 – 2025 (US$ Mn)

Chapter 6. Company Profiles
6.1. Acelity
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Alliqua Biomedical
6.3. BMG Pharma S.R.L.
6.4. Convatec, Inc.
6.5. Derma Sciences, Inc.
6.6. Intermed Pharmaceuticals
6.7. Molnlycke Health Care AB
6.8. Smith & Nephew plc
6.9. Stratpharma AG
6.10. 3M Healthcare
6.11. Other Notable Players

You can get the sample copy of this research by Acute Market Reports here: https://www.acutemarketreports.com/sample-request/58693

About Acute Market Reports (Original Publisher)

Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,


Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@acutemarketreports.com

Website: http://www.acutemarketreports.com

Leave a Reply

Your email address will not be published. Required fields are marked *